Expression Of Protein Kinase Eml4-Alk Gene In Non-Small Cell Lung Cancer In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America

Between 2-5% of patients with Non-Small Cell Lung Cancer (NSCLC), younger tan 50 years, present ALK (Anaplastic Lymphoma Kinase) and EML4 (Echinoderm Microtubule-associated protein Like 4) gene fusions causing inversion in chromosome2.

Autores:
Fernández, Liliana
Restrepo, Juan G.
Muñoz, Carlos A.
Sua, Luz F.
Tipo de recurso:
Informe
Fecha de publicación:
2016
Institución:
Universidad ICESI
Repositorio:
Repositorio ICESI
Idioma:
eng
OAI Identifier:
oai:repository.icesi.edu.co:10906/81357
Acceso en línea:
http://nebulosa.icesi.edu.co:2143/full_record.do?product=WOS&search_mode=GeneralSearch&qid=9&SID=3Dr7QVLgmeqIWKgWekv&page=1&doc=1
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A2588
http://hdl.handle.net/10906/81357
Palabra clave:
Ciencias socio biomédicas
Cáncer de pulmón
Quinasas
Fundación Valle del Lili
Medical sciences
Rights
openAccess
License
http://purl.org/coar/access_right/c_abf2
Description
Summary:Between 2-5% of patients with Non-Small Cell Lung Cancer (NSCLC), younger tan 50 years, present ALK (Anaplastic Lymphoma Kinase) and EML4 (Echinoderm Microtubule-associated protein Like 4) gene fusions causing inversion in chromosome2.